Canada Markets open in 32 mins

Bausch Health Companies Inc. (BHC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
7.31+0.27 (+3.84%)
At close: 04:00PM EDT
7.58 +0.27 (+3.69%)
Pre-Market: 08:47AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close7.04
Open7.00
Bid7.36 x 1000
Ask0.00 x 3000
Day's Range6.97 - 7.63
52 Week Range4.00 - 29.31
Volume8,958,190
Avg. Volume8,922,725
Market Cap2.627B
Beta (5Y Monthly)1.66
PE Ratio (TTM)N/A
EPS (TTM)-1.58
Earnings DateOct 31, 2022 - Nov 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 10, 2010
1y Target Est20.08
  • Baystreet

    Stocks in play: Bausch Health Companies Inc.

    And Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) announced that ...

  • CNW Group

    Bausch Health and Glenmark Announce the approval of RYALTRIS® in Canada

    Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC) ("Bausch Health") and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark), are pleased to announce that RYALTRIS® (olopatadine hydrochloride and mometasone furoate nasal spray) has been approved by Health Canada for the symptomatic treatment of moderate to severe seasonal allergic rhinitis (SAR) and associated ocular symptoms in adults, adolescents, and children aged 6 years and older.1

  • The Motley Fool

    1 Canadian Stock up 30% in a Month and Climbing

    Bausch Health (TSX:BHC)(NYSE:BHC) stock is climbing back with the separation of its Bausch + Lomb shares looking imminent. The post 1 Canadian Stock up 30% in a Month and Climbing appeared first on The Motley Fool Canada.